Gainers
- Greenlane Holdings GNLN shares gained 1.19%, closing at $3.40.
- Innovative Industrial IIPR shares gained 0.7%, closing at $82.55.
- Akerna KERN shares rose 5.56%, to close at $3.80.
- Alcanna LQSIF shares increased by 4.1% to close at $3.35.
- MedMen Enterprises MMNFF shares rose 0.46%, to close at $1.02.
Losers
- Aurora Cannabis ACB shares dropped by 7.04%, to close at $3.30.
- Aphria APHA shares fell 1.12% to close at $4.41.
- Columbia Care CCHWF shares dropped by 6.98%, to close at $2.72.
- Canopy Growth CGC shares dropped by 14.43%, to close at $15.83 after missing revenue and EPS estimates.
- Cresco Labs CRLBF shares tumbled by 6.59%, eventually closing at $5.53.
- Cronos Group CRON shares tumbled by 6.06%, eventually closing at $6.82.
- CannTrust Holdings CTST shares fell 8.5% to close at $0.89.
- Fire & Flower Holdings FFLWF shares fell 6.19% to close at $0.60.
- GW Pharmaceuticals GWPH shares dropped by 4.52%, to close at $106.01.
- HEXO HEXO shares dropped by 5.53%, to close at $1.88.
- Harvest Health HRVSF shares tumbled by 2.39%, eventually closing at $2.65.
- KushCo Holdings KSHB shares dropped by 0.62%, to close at $1.61.
- MediPharm Labs MEDIF shares tumbled by 7.93%, eventually closing at $3.02.
- OrganiGram Holdings OGI shares fell 1.59% to close at $2.47.
- Planet 13 Holdings PLNHF shares tumbled by 6.22%, eventually closing at $1.51.
- Pyxus International PYX shares fell 5.1% to close at $8.74.
- Sundial Growers SNDL shares tumbled by 9.7%, eventually closing at $3.26 after reporting a wider than expected net loss.
- Supreme Cannabis Co SPRWF shares dropped by 2.62%, to close at $0.58.
- Tilray TLRY shares dropped by 5.35%, to close at $19.81.
- Therapix Biosciences TRPX shares fell 11.05% to close at $1.53.
- Valens Groworks VGWCF shares tumbled by 2.25%, eventually closing at $2.36.
- cbdMD YCBD shares tumbled by 10.16%, eventually closing at $3.36.
- Zynerba Pharmaceuticals ZYNE shares dropped by 4.68%, to close at $6.11.
Related Links:
Canopy Rivers Stock Tumbles On Q2 Results
Cannabis Ads Finally Hitting BuzzFeed, Thrillist And USA Today
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.